Arsenic exposure, dermatological lesions, hypertension, and chromosomal abnormalities among people in a rural community of northwest Iran

Journal of Health, Population and Nutrition

Volumn 28, Issue 1, 2010, Pages 14-22

  Dastgiri, Saeed ^a   Mosaferi, Mohammad ^b   Fizi, Mohammad A H ^c   Olfati, Nahid ^a   Zolali, Shahin ^d   Pouladi, Nasser ^e   Azarfam, Parvin ^c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b School of Health and Nutrition   (Iran)

^c UNIVERSITY OF TABRIZ   (Iran)

^d AVICENNA RESEARCH INSTITUTE   (Iran)

^e AZARBAIJAN SHAHID MADANI UNIVERSITY   (Iran)

Author keywords

Arsenic; Chromosomal abnormalities; Cross sectional studies; Dermatological lesions; Hypertension; Iran; Water pollution; Water supply

Indexed keywords

ARSENIC;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; CHROMOSOME ABERRATION; COMORBIDITY; CROSS-SECTIONAL STUDY; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGY; EPIDERMOLYTIC HYPERKERATOSIS; FEMALE; HEALTH; HOSPITALIZATION; HUMAN; HYPERTENSION; IRAN; MALE; PIGMENT DISORDER; RISK; RURAL POPULATION; STATISTICS; WATER POLLUTANT; WATER POLLUTION; WATER SUPPLY;

ADULT; AGE DISTRIBUTION; ARSENIC; BLOOD PRESSURE; CAUSALITY; CHROMOSOME ABERRATIONS; COMORBIDITY; CROSS-SECTIONAL STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; HYPERKERATOSIS, EPIDERMOLYTIC; HYPERTENSION; IRAN; MALE; ODDS RATIO; PIGMENTATION DISORDERS; RURAL HEALTH; RURAL POPULATION; SEVERITY OF ILLNESS INDEX; WATER POLLUTANTS; WATER POLLUTION; WATER SUPPLY;

EID: 77951249222     PISSN: 16060997     EISSN: None     Source Type: Journal    
DOI: 10.3329/jhpn.v28i1.4519     Document Type: Article

References (66)

1. Agency for Toxic Substances and Disease Registry. Toxicological profile for arsenic TP2. Atlanta, GA: Centers for Disease Control and Prevention, 2005:1-15.
2. World Health Organization. Arsenic and arsenic compounds. 2nd ed. Geneva: World Health Organization, 2001:1-8. (Environmental health criteria, v. 224).
3. Rousselot P, Laboume S, Marolleau JP, Larghero T, Noguera ML, Brouet JC et al. Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patient. Cancer Res 1999;59:1041-8.
4. Evens AM, Tallman MS, Gartenhaus RB. The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future. Leukemia Res 2004;28:891-900.
5. Petrusevski B, Sharma SK, Schippers JC, Shordt K. Arsenic in drinking water. Delft: IRC International Water and Sanitation Centre, 2007:1-11 (Thematic overview paper no. 17).
6. Tseng CH. Cardiovascular disease in arsenic-exposed subjects living in the arseniasis-hyperendemic areas in Taiwan (review). Atherosclerosis 2008;199:12-8.
7. Rahman MM, Chowdhury UK, Mukherjee SC, Mondal BK, Paul K, Lodh D et al. Chronic arsenic toxicity in Bangladesh and West Bengal, India, a review and commentary. J Toxicol Clin Toxicol 2001;39:683-700.
8. Mukherriee A, Sengupta MK, Hossain MA, Ahamed S, Das B, Navak B et al. Arsenic contamination in groundwater: a global perspective with emphasis on the Asian scenario. J Health Popul Nutr 2006;24:142-63.
9. Mosaferi M, Yunesian M, Dastgiri S. Mesdaghinia A, Esmailnasab N. Prevalence of skin lesions and exposure to arsenic in drinking water in Iran. Sci Total Environ 2008;390:69-76.
10. Mosaferi M, Hassani AM, Borghei M, Kamali Z, Ghadirzadeh A. Study of arsenic presence in drinking water sources: a case study. Iran J Health Environ 2008;1:18-27 [Persian].
11. World Health Organization. Guidelines for drinkingwater quality. Geneva: World Health Organization, 1993:41.
12. th ed. Tehran: Institute of Standard and Industrial Research of Iran, 1996:5.
13. Uchino T, Roychowdhury T, Ando M, Tokunaga H. Intake of arsenic from water, food composites and excretion through urine, hair from a studied population in West Bengal, India. Food Chem Toxicol 2006;44:455-61.
14. Yoshida T, Yamauchi H, Sun GF. Chronic health effects in people exposed to arsenic via the drinking water-dose response relationships in review. Toxicol Appl Pharmacol 2004;198:243-52.
15. Nickson R, McArthur J, Burgess W, Ahmed KM, Ravenscroft P, Rahman M. Arsenic poisoning of Bangladesh groundwater (letter). Nature 1998;395:338.
16. Gebel TW. Arsenic and drinking water contamination. Science 1999;283:1458-9.
17. Sun G. Arsenic contamination and arsenicosis in China. Toxicol Appl Pharmacol 2004;198:268-71.
18. Kapaj S, Peterson H, Liber K, Bhattacharya P. Human health effects from chronic arsenic poisoning: a review. J Environ Sci Health A: Tox Hazard Subst Environ Eng 2006;41:2399-428.
19. Tsuchiya K. Various factors influencing toxicity and metabolism of metals--metal-metal interactions and host factors [author's transl]. Sangyo Igaku 1977;19:471-8.
20. Ferreccio C, Sancha AM. Arsenic exposure and its impact on health in Chile. J Health Popul Nutr 2006;24:164-75.
21. Mitra SR, Mazumder DN, Basu A, Block G, Haque R, Samanta S et al. Nutritional factors and susceptibility to arsenic-caused skin lesions in West Bengal, India. Environ Health Perspect. 2004;112:1104-9.
22. Kristiansen J, Christensen JM, Iversen BS, Sabbioni E. Toxic trace element reference levels in blood and urine: influence of gender and lifestyle factors. Sci Total Environ 1997;204:147-60.
23. Navas-Acien A, Sharret AR, Silbergeld EK, Schwartz BS, Nachman KE, Burke TA et al. Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am J Epidemiol 2005;162:1037-49.
24. Tseng CH, Chong CK, Tseng CP, Hsueh YM, Chiou HY, Tseng CC et al. Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan. Toxicol Lett 2003;137:15-21.
25. Chiou HY, Huang WI, Su CL, Chang SF, Hsu YH, Chen CJ. Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke 1997;28:1717-23.
26. Wang CH, Jeng JS, Yip PK, Chen CL, Hsu LI, Hsueh YM et al. Biological gradient between long-term arsenic exposure and carotid atherosclerosis. Circulation 2002;105:1804-9.
27. Chen CJ, Hsueh YM, Lai MS, Shyu MP, Chen SY, Wu MM et al. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 1995;25:53-60.
28. Rahman M, Tondel M, Ahmad SA, Chowdhury IA, Faruquee MH, Axelson O. Hypertension and arsenic exposure in Bangladesh. Hypertension 1999;33:74-8.
29. Engel RR, Hopenhayn-Rich C, Receveur O, Smith AH. Vascular effects of chronic arsenic exposure: a review. Epidemiol Rev 1994;16:184-209.
30. Simeonova PP, Luster MI. Arsenic and atherosclerosis. Toxicol Appl Pharmacol 2004;198:444-9.
31. Tseng CH, Chong CK, Chen CJ, Tai TY. Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. Atherosclerosis 1996;120:125-33.
32. Kumagai Y, Pi J. Molecular basis for arsenic-induced alteration in nitric oxide production and oxidative stress: implication of endothelial dysfunction. Toxicol Appl Pharmacol 2004;198:450-7.
33. Tseng WP. Blackfoot disease in Taiwan: a 30-year follow-up study. Angiology 1989;40:547-58.
34. Chen CJ, Wang CJ. Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res 1990;50:5470-4.
35. Chen CJ, Chuang YC, Lin TM, Wu HY. Malignant neoplasms among residents of a blackfoot diseaseendemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res 1985;45:5895-9.
36. Chen CJ, Chen CW, Wu MM, Kuo TL. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer 1992;66:888-92.
37. Chiou HY, Chiou ST, Hsu YH, Chou YL, Tseng CH, Wei ML et al. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol 2001;153:411-8.
38. Schwerdtle T, Walter I, Mackiw I, Hartwig A. Induction of oxidative DNA damage by arsenite and its trivalent and pentavalent methylated metabolites in cultured human cells and isolated DNA. Carcinogenesis 2003;24:967-74.
39. Yu HS, Liao WT, Chai CY. Arsenic carcinogenesis in the skin. J Biomed Sci 2006;13:657-66.
40. Chiou HY, Hsueh YM, Liaw KF, Horng SF, Chiang MH, Pu YS et al. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res 1995;55:1296-300.
41. Liu YT, Chen Z. A retrospective lung cancer mortality study of people exposed to insoluble arsenic and radon. Lung Cancer 1996;14:137-48.
42. Abernathy C, Morgan A. Exposure and health effects. Chapter 3: United Nations synthesis report on arsenic in drinking water (first draft). Washington, DC: Office of Water, Health and Ecological Criteria Division, US Environmental Protection Agency, 2001:71.
43. Tapio S, Grosche B. Arsenic in the aetiology of cancer. Mutation Res 2006;612:215-46.
44. Navas-Acien A, Silbergeld EK, Streeter RA, Clark JM, Burke TA, Guallar E. Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiologic evidence. Environ Health Perspect 2006;114:641-8.
45. Tseng CH, Tseng CP, Chiou HY, Hsueh YM, Chong CK, Chen CJ. Epidemiologic evidence of diabetogenic effect of arsenic. Toxicol Lett 2002;133:69-76.
46. Calderon J, Navarro ME, Jimenez-Capdeville ME, Santos-Diaz MA, Golden A, Rodriguez-Leyva I et al. Exposure to arsenic and lead and neuropsychological development in Mexican children. Environ Res 2001;85:69-76.
47. Grandjean P, Landrigan PJ. Developmental neurotoxicity of industrial chemicals. Lancet 2006;368:2167-78.
48. Yoshida T, Yamauchi H, Fan Sun G. Chronic health effects in people exposed to arsenic via the drinking water: dose-response relationships in review. Toxicol Appl Pharmacol 2004;198:243-52.
49. Mazumder DNG. Chronic arsenic toxicity: clinical features, epidemiology, and treatment: experience in West Bengal. J Environ Sci Health A: Tox Hazard Subst Environ Eng 2003;38:141-63.
50. Tseng WP. Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic. Environ Health Perspect 1977;19:109-19.
51. Wang YH, Wu MM, Hong CT, Lien LM, Hsieh YC, Tseng HP et al. Effects of arsenic exposure and genetic polymorphisms of p53, glutathione S-transferase M1, T1, and P1 on the risk of carotid atherosclerosis in Taiwan. Atherosclerosis 2007;192:305-12.
52. Mahata J, Chaki M, Ghosh P, Das LK, Baidya K, Ray K et al. Chromosomal aberrations in arsenic-exposed human populations: a review with special reference to a comprehensive study in West Bengal. India. Cytogenet Genome Res 2004;104:359-64.
53. Sordo M, Herrera LA, Ostrosky-Wegman P, Rojas E. Cytotoxic and genotoxic effects of As, MMA, and DMA on leukocytes and stimulated human lymphocytes. Teratog Carcinog Mutagen 2001;21:249-60.
54. Abernathy CO, Liu YP, Longfellow D, Aposhian HV, Beck B, Fowler B et al. Arsenic: health effects, mechanisms of actions, and research issues. Environ Health Perspect 1999;107:593-7.
55. Dopp E, Hartmann LM, Florea AM, von Recklinghausen U, Pieper R, Shokouhi B et al. Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells. Toxicol Appl Pharmacol 2004;201:156-65.
56. Hughes MF. Arsenic toxicity and potential mechanisms of action. Toxicol Lett 2002;133:1-16.
57. Chen CJ, Hsueh YM, Chiou HY, et al. Human carcinogenicity of inorganic arsenic. In: Abernathy CO, Calderon RL, Chappell WR, editors. Arsenic: exposure and health effects. London: Chapman and Hall Ltd., 1997:232-42.
58. Iran national portal of statistics. 2008. (http://www.sci.org.ir/portal/faces/public/sci, accessed 16 May 2009).
59. th ed. Washington, DC: American Public Health Association, 1998. 1,325 p.
60. Guha Mazumder DN. Diagnosis and treatment of chronic arsenic poisoning. Geneva: World Health Organization, 2000:1-45.
61. Guo X, Liu Z, Huang C, You L. Levels of arsenic in drinking water and cutaneous lesions in Inner Mongolia. J Health Popul Nutr 2006;24:214-20.
62. Mosaferi M, Yunesian M, Mesdaghinia AR, Nasseri S, Mahvi AH, Nadim H. Correlation between arsenic concentration of drinking water and hair. Iran J Environ Health Sci Eng 2005;2:11-23.
63. Tondel M, Rahman M, Magnuson A, Chowdhury IA, Faruquee MH, Ahmad SA. The relationship of arsenic levels in drinking water and the prevalence rate of skin lesions in Bangladesh. Environ Health Perspect 1999;107:727-9.
64. Huang YK, Tseng CH, Huang YL, Yang MH, Chen CJ, Hsueh YM. Arsenic methylation capability and hypertension risk in subjects living in arseniasis-hyperendemic areas in southwestern Taiwan. Toxicol Appl Pharmacol 2007;218:135-42.
65. Ling HL, Xia Y, Lobdell D, Zeng D, Thorp JM, Creason JP et al. Drinking water arsenic exposure and blood pressure in healthy women of reproductive age in Inner Mongolia, China. Toxicol Appl Pharmacol 2007;222:337-43.
66. Perez-Carrera A, Fernandez-Cirelli A. Arsenic concentration in water and bovine milk in Cordoba, Argentina: preliminary results. J Dairy Res 2005;72:122-4.